Prof. LindaChao | cognitive neuroscience | Best Researcher Award

Prof. LindaChao | cognitive neuroscience | Best Researcher Award šŸ†

Professor/Research Career Scientist at UCSF/San Francisco VA Health Care SystemšŸŽ“

Dr. Linda L. Chao is a highly respected neuroscientist whose journey began with a B.S. in Biological Sciences and a Ph.D. in Neuroscience from UC Davis. Following her postdoctoral training as a Cognitive Neuroscience Fellow at the National Institute of Mental Health, Dr. Chao joined UCSF, where she is now a Professor in Radiology, Psychiatry, and Behavioral Sciences. She also contributes significantly to veteran health research at the San Francisco VA Medical Center. Renowned for her expertise in cognitive neuroscience and neuroimaging, Dr. Chao employs advanced MRI, PET, and fMRI techniques to study neurodegenerative diseases, Gulf War Illness, and PTSD. Her groundbreaking work in non-pharmacological therapies for Alzheimerā€™s and trauma-related conditions has earned her prestigious awards, including the UC Davis Graduate Research Award and the NIMH Fellows Award for Research Excellence. As an active member of key neuroscience organizations and a dedicated mentor, Dr. Chao is a vital figure in advancing mental health research and neuroimaging innovations.

Professional ProfileĀ 

Education šŸŽ“:

Dr. Linda L. Chao earned her B.S. in Biological Sciences (1987-1991) and a Ph.D. in Neuroscience (1991-1996) from the University of California, Davis. Her dedication to understanding the brain and its functions began here, paving the way for her groundbreaking work in neuroscience and cognitive research.

 

Work Experience šŸ’¼:

Dr. Chao’s career reflects a strong commitment to advancing mental health research. Her postdoctoral training took place at the National Institute of Mental Health (NIMH) as a Cognitive Neuroscience Fellow (1996-2000). She joined the University of California, San Francisco (UCSF) as an Assistant Professor in Radiology and Psychiatry in 2001, advancing to Associate Professor and later Professor in the departments of Radiology & Biomedical Imaging, Psychiatry, and Behavioral Sciences. She also holds a significant role with the San Francisco VA Medical Center, where she contributes to research safety and promotes veteran health.

 

Skills šŸ”

Dr. Chao is highly skilled in cognitive neuroscience, neuroimaging, and radiology. She has expertise in analyzing brain health through MRI, PET, and fMRI imaging techniques. Her experience extends to research safety, clinical trials, and therapeutic interventions for neurodegenerative diseases and Gulf War Illness. Her innovative skills in cognitive and neuroimaging research support her work in developing non-pharmacological interventions for conditions like PTSD and Alzheimerā€™s.

 

Awards and Honors šŸ†

Dr. Chaoā€™s research excellence is recognized with numerous awards, including the University of California, Davis Graduate Research Award (1994) and the Fellows Award for Research Excellence from the National Institute of Mental Health (1999). These honors underscore her significant contributions to cognitive neuroscience and clinical research.

 

šŸ¤ Memberships:

Dr. Chao is actively involved in multiple professional organizations, including the Society for Neuroscience (SFN), Cognitive Neuroscience Society (CNS), and the International Society to Advance Alzheimerā€™s Research and Treatment (ISAART). Her memberships reflect her dedication to staying at the forefront of neuroscience, cognitive health, and clinical research.

Teaching Experience šŸ‘©ā€šŸ«:

With a passion for mentoring, Dr. Chao has taught at UCSF’s School of Medicine, facilitating courses on brain, mind, and behavior. She has lectured on clinical fMRI applications and led seminars on neuroimaging. Her role as a mentor has influenced many students and researchers in radiology, psychology, and psychiatry, shaping the future of neuroscience.

 

Research Focus šŸ”¬:

Dr. Chao’s research primarily explores cognitive function, neurodegenerative diseases, and neuroimaging in veterans. Her work on Gulf War Illness and the effects of sarin exposure highlights her commitment to understanding trauma impacts on the brain. Additionally, she investigates photobiomodulation therapies, non-pharmacological dementia treatments, and PTSD interventions. Her recent studies reveal the complex interactions between genetic factors and environmental exposures affecting brain health.

ConclusionĀ 

Dr. Linda L. Chao is a deserving candidate for the Best Researcher Award. Her remarkable contributions to cognitive neuroscience, dedication to mentoring, and commitment to understanding the brain’s response to trauma and neurotoxic exposure make her a vital asset to the field. With her current momentum and slight expansion in her researchā€™s reach and collaboration, Dr. Chao is well-positioned to continue making substantial, globally impactful advancements in neuroscience.

šŸ“š PublilcationĀ 

  • Topic: Implementing a new multidisciplinary, remote, dementia staff training program for Veterans Affairs nursing homes
    • Year: 2024
    • Journal: BMC Health Services Research
  • Topic: Olfactory and cognitive decrements in 1991 Gulf War veterans with Gulf War illness/chronic multisymptom illness
    • Year: 2024
    • Journal: Environmental Health: A Global Access Science Source
  • Topic: Current health status of Gulf War deployed and Gulf War era veterans who use Veterans Affairs health care
    • Year: 2024
    • Journal: Journal of Women’s Health
  • Topic: PON1 status in relation to Gulf War Illness: Evidence of geneā€“exposure interactions from a multisite caseā€“control study of 1990ā€“1991 Gulf War veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Gulf War illness is associated with host gut microbiome dysbiosis and is linked to altered species abundance in veterans from the BBRAIN cohort
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Livestream, group movement program for people living with cognitive impairment and care partners: A randomized clinical trial
    • Year: 2024
    • Journal: Alzheimer’s and Dementia: Translational Research and Clinical Interventions
  • Topic: Characterizing 1991 Gulf War women veterans from the Boston Biorepository and Integrative Network for Gulf War Illness: Demographics, exposures, neuroimaging, and cognitive outcomes
    • Year: 2024
    • Journal: Clinical Neuropsychologist
  • Topic: Cognitive decrements in 1991 Gulf War veterans: Associations with Gulf War illness and neurotoxicant exposures in the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) cohorts
    • Year: 2023
    • Journal: Environmental Health: A Global Access Science Source

 

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Dr. Amira Boseila | Neuroscience| Best Researcher AwardšŸ†


Lecturer at Sinai University,EgyptšŸŽ“

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional ProfileĀ 

šŸŽ“ Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

šŸ¢ Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

šŸ§¬ Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors šŸ†

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

šŸ”¬ Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

šŸ“š PublicationĀ 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiotaā€“Gutā€“Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the ā€œEra of the-Greenā€: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and Ī²-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014